106 related articles for article (PubMed ID: 17695798)
1. [IgM antibody detection in acute viral diseases, 1995-2004: analysis of data collected at a commercial diagnostic laboratory in Japan].
Ban F; Itabashi Y; Masui Y; Inouye S
Kansenshogaku Zasshi; 2007 Jul; 81(4):426-34. PubMed ID: 17695798
[TBL] [Abstract][Full Text] [Related]
2. [Study of the antibodies against measles, rubella, mumps and varicella-zoster viruses in sera from the medical staffs].
Shiraishi T; Nakagawa M; Nakagawa Y; Tominaga M; Yoshitani S
Kansenshogaku Zasshi; 2005 May; 79(5):322-8. PubMed ID: 15977572
[TBL] [Abstract][Full Text] [Related]
3. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.
Naganuma M; Nagahori M; Fujii T; Morio J; Saito E; Watanabe M
Inflamm Bowel Dis; 2013 Feb; 19(2):418-22. PubMed ID: 22605673
[TBL] [Abstract][Full Text] [Related]
4. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
5. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
[TBL] [Abstract][Full Text] [Related]
6. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection.
Thomas HI; Barrett E; Hesketh LM; Wynne A; Morgan-Capner P
J Clin Virol; 1999 Oct; 14(2):107-18. PubMed ID: 10588453
[TBL] [Abstract][Full Text] [Related]
8. Time-Series Analysis Comparing the Prevalence of Antibodies against Nine Viral Species Found in Umbilical Cord Blood in Japan.
Takemoto K; Nishimura N; Kozawa K; Hibino H; Kawaguchi M; Takeuchi S; Fujishiro N; Arai S; Gotoh K; Hosono H; Ozaki T
Jpn J Infect Dis; 2016 Jul; 69(4):314-8. PubMed ID: 26567842
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the specificity of a commercial human parvovirus B19 IgM assay.
Jensen IP; Vestergaard BF
Clin Diagn Virol; 1997 Feb; 7(3):133-7. PubMed ID: 9126681
[TBL] [Abstract][Full Text] [Related]
10. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes].
Wolff MH; Marklein G; Schneweis KE; Stifter G
Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618
[No Abstract] [Full Text] [Related]
11. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
12. No changes in paired viral antibody titers during the course of acute schizophrenia.
Fukuda R; Sasaki T; Kunugi H; Nanko S
Neuropsychobiology; 1999; 40(2):57-62. PubMed ID: 10474057
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of medical students to vaccine-preventable viral diseases: a serological study.
Kukino J; Naito T; Mitsuhashi K; Oshima H; Sekiya S; Isonuma H; Watanabe K; Dambara T; Hayashida Y
J Infect Chemother; 2004 Dec; 10(6):335-7. PubMed ID: 15614457
[TBL] [Abstract][Full Text] [Related]
14. [2007 measles outbreaks among Tokyo youths: analysis of data on serum IgM antibody detection at a commercial diagnostic laboratory].
Ban F; Masui Y; Inouye S
Kansenshogaku Zasshi; 2008 May; 82(3):198-204. PubMed ID: 18546849
[TBL] [Abstract][Full Text] [Related]
15. [The immunoassay of IgM antibodies in samples clinically suspected of measles].
Ribas Antúnez MA; Arocha Rosete Y; Toraño Canto I; Rodríguez Valdés C
Rev Cubana Med Trop; 1998; 50(2):105-9. PubMed ID: 10349427
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
Buxbaum S; Doerr HW; Allwinn R
Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
[TBL] [Abstract][Full Text] [Related]
17. The use of IgM antibody responses in the diagnosis of primary infections to measles, rubella, mumps, and M. Parainfluenzae viruses.
Bringuier JP; Andre J; Sohier R
Med Microbiol Immunol; 1978; 164(4):299-305. PubMed ID: 45605
[TBL] [Abstract][Full Text] [Related]
18. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.
Smits GP; van Gageldonk PG; Schouls LM; van der Klis FR; Berbers GA
Clin Vaccine Immunol; 2012 Mar; 19(3):396-400. PubMed ID: 22237896
[TBL] [Abstract][Full Text] [Related]
19. [A rapid method for the determination of virus-specific IgM antibodies].
Goetz O; Peller P; Oettrich K
Infection; 1982; 10(5):267-70. PubMed ID: 6293973
[TBL] [Abstract][Full Text] [Related]
20. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]